Christopher T. Ritchlin, MD, MPH

University of Rochester Medical Center
Canandaigua, NY, United States

Dr. Ritchlin is Professor in the Allergy, Immunology & Rheumatology Division at the University of Rochester Medical Center

Disclosure information not submitted.

Presentation(s):

• 13S158: Abstracts: Spondyloarthritis Including PsA – Treatment II: PsA (1597–1602)

  Sunday, November 13, 2022
  3:00 PM – 4:30 PM Eastern Time

• L02: Bimekizumab Treatment in Biologic DMARD-Naïve Patients with Active Psoriatic Arthritis: 52-Week Efficacy and Safety Results from a Phase 3, Randomized, Placebo-Controlled, Active Reference Study

  Monday, November 14, 2022
  9:15 AM – 9:25 AM Eastern Time

• 2112: Stringent Disease Activity Control at 2 Years Across Psoriatic Arthritis Domains Irrespective of Baseline Characteristics in Patients Treated with Guselkumab: Post Hoc Analysis of a Phase 3, Randomized, Double-blind, Placebo-controlled Study

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time